Surveillance Study of Viral Infections Following Lung Transplantation

NCT00701922 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 388

Last updated 2011-10-28

No results posted yet for this study

Summary

The present study was conducted to study the impact community acquired respiratory virus (CARV) infections in an outpatient setting on graft function of lung transplant recipients. The study was aimed to identify risk factors for CARV infections.

The study was further intended to investigate an association of Epstein-Barr virus (EBV), cytomegalovirus (CMV) and human adenovirus (HAdV) with the development of BOS and to identify risk factors for virus detection in blood.

Conditions

  • Lung Transplantation
  • Bronchiolitis Obliterans
  • Epstein-Barr Virus Infections
  • Paramyxoviridae Infections

Sponsors & Collaborators

  • Department of Pulmonology

    collaborator UNKNOWN
  • Department of Virology

    collaborator AMBIG
  • Hannover Medical School

    lead OTHER

Principal Investigators

  • Jens T Gottlieb, MD · Dpt. Pulmonary Medicine

  • Ilka Engelmann, MD · Dpt. Virology, MHH

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-10-31
Primary Completion
2007-12-31
Completion
2007-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00701922 on ClinicalTrials.gov